Clorox (NYSE:CLX) Given New $100.00 Price Target at Wells Fargo & Company

Clorox (NYSE:CLXFree Report) had its target price lowered by Wells Fargo & Company from $110.00 to $100.00 in a report issued on Friday morning,Benzinga reports. Wells Fargo & Company currently has an equal weight rating on the stock.

Several other research firms have also recently weighed in on CLX. The Goldman Sachs Group dropped their price target on shares of Clorox from $110.00 to $94.00 and set a “sell” rating for the company in a research note on Wednesday, January 7th. Rothschild & Co Redburn set a $117.00 price objective on Clorox in a report on Friday, February 13th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $91.00 price objective on shares of Clorox in a research report on Friday. BNP Paribas Exane upgraded Clorox from an “underperform” rating to a “neutral” rating in a research report on Wednesday, February 11th. Finally, Barclays set a $85.00 price target on Clorox in a research note on Friday. One analyst has rated the stock with a Buy rating, twelve have given a Hold rating and four have assigned a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Reduce” and an average price target of $104.93.

Get Our Latest Analysis on Clorox

Clorox Trading Down 9.7%

Shares of CLX traded down $9.36 during midday trading on Friday, reaching $87.08. The company had a trading volume of 13,250,607 shares, compared to its average volume of 2,359,509. Clorox has a 1-year low of $86.00 and a 1-year high of $140.24. The company has a quick ratio of 0.48, a current ratio of 0.74 and a debt-to-equity ratio of 71.03. The firm has a 50 day simple moving average of $108.21 and a 200-day simple moving average of $108.82. The stock has a market cap of $10.53 billion, a PE ratio of 14.23, a price-to-earnings-growth ratio of 0.48 and a beta of 0.65.

Clorox (NYSE:CLXGet Free Report) last announced its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 379.46%. The firm had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.67 billion. During the same quarter in the prior year, the firm posted $1.45 earnings per share. Clorox’s quarterly revenue was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Research analysts forecast that Clorox will post 5.87 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, May 8th. Stockholders of record on Wednesday, April 22nd will be given a dividend of $1.24 per share. This represents a $4.96 annualized dividend and a dividend yield of 5.7%. The ex-dividend date is Wednesday, April 22nd. Clorox’s dividend payout ratio (DPR) is currently 81.05%.

Hedge Funds Weigh In On Clorox

Several hedge funds have recently bought and sold shares of the company. Norges Bank acquired a new position in Clorox in the 4th quarter valued at about $135,735,000. Van ECK Associates Corp increased its stake in Clorox by 93.9% during the third quarter. Van ECK Associates Corp now owns 2,709,972 shares of the company’s stock worth $334,139,000 after purchasing an additional 1,312,471 shares during the period. Invesco Ltd. lifted its position in shares of Clorox by 22.1% during the fourth quarter. Invesco Ltd. now owns 4,880,341 shares of the company’s stock worth $492,085,000 after purchasing an additional 884,751 shares in the last quarter. Northwestern Mutual Wealth Management Co. boosted its stake in shares of Clorox by 6,907.9% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 749,703 shares of the company’s stock valued at $75,593,000 after purchasing an additional 739,005 shares during the period. Finally, Worldquant Millennium Advisors LLC acquired a new position in shares of Clorox in the second quarter valued at approximately $71,856,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

More Clorox News

Here are the key news stories impacting Clorox this week:

  • Positive Sentiment: Q3 results beat on the bottom line as cost cuts and lower spending lifted non‑GAAP EPS to $1.64, above estimates, showing operational leverage despite flat sales. Read More.
  • Positive Sentiment: Management is emphasizing innovation and strategic moves to drive future growth — a narrative investors may watch if execution improves. Read More.
  • Neutral Sentiment: The company provided Q3 filings, an earnings call transcript and a formal press release; these sources contain details on segment trends and cost actions for modeling. Read More.Read More.
  • Negative Sentiment: Clorox trimmed FY‑2026 guidance (EPS and sales), citing weaker demand and market‑share headwinds — management’s guidance was well below consensus, which is the main catalyst for the selloff. Read More.
  • Negative Sentiment: Several large brokers cut price targets and shifted to neutral/underweight after the update (Morgan Stanley, Citi, JPMorgan, Wells Fargo), increasing short‑term selling pressure. Read More.Read More.
  • Negative Sentiment: A shareholder law firm announced an investigation into possible securities‑fraud claims related to Clorox’s statements, adding regulatory/legal risk that can weigh on sentiment. Read More.
  • Negative Sentiment: Shares hit new 52‑week lows and traded at much higher volumes, signaling broad repositioning by investors and momentum that could continue until clarity on sales/margin recovery arrives. Read More.

About Clorox

(Get Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Read More

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.